Yet Hong Khor

I would like to thank the Asian Pacific Society of Respirology and International Society for Respiratory Diseases for inviting me to present my research at the joint session at the 2019 American Thoracic Society International Conference. This year, the American Thoracic Society International Conference was held from 17 to 22 May 2019 in Dallas, USA, with over 15,000 attendees including basic scientists, clinicians, educators and exhibitors, all from a variety of disciplines and continents. This 6-day education event has immensely expanded my knowledge in respiratory medicine and broadened my international network.

In addition to the joint APSR-ISRD session, I presented my study, "A Pilot Randomised Controlled Trial of Ambulatory Oxygen versus Air via Portable Concentrator in Fibrotic Interstitial Lung Disease", during the ILD Therapy Rapid Poster Discussion session. I also presented another abstract, "Prognosis of adults with idiopathic pulmonary fibrosis without effective therapies: a systematic review and meta-analysis" during a thematic poster session. It was a fantastic opportunity for me to share my research with experts in the field of patient care in interstitial lung disease from around the world.

During the conference, I had the opportunity to meet and engage with international prominent researchers in interstitial lung diseases. I was invited to attend the Canadian Registry for Pulmonary Fibrosis Meeting and establish collaborative research programmes to study disease trajectories and patient care in interstitial lung disease.

This participation has been incredibly valuable in broadening knowledge, skills and opportunities for collaboration. It has been an invaluable experience for enhancing my professional profile within the international scientific community and for developing my career. I would like to thank the Asian Pacific Society of Respirology and International Society for Respiratory Diseases for continued support for early career researchers.